UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents

Läkartidningen, 2006-09, Vol.103 (39), p.2838

Stenestrand, Ulf

2006

Volltextzugriff (PDF)

Drug-eluting stents in coronary arteries. The risk of restenosis is drastically reduced

Läkartidningen, 2004-12, Vol.101 (51-52), p.4175-4175

Tornvall, Per

2004

Volltextzugriff (PDF)

Drug-eluting stents can increase the risk of late stent thrombosis

Läkartidningen, 2006-09, Vol.103 (39), p.2845

2006

Volltextzugriff (PDF)

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

European heart journal, 2015-12, Vol.36 (47), p.3320-3331

2015

Volltextzugriff (PDF)

6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial

Journal of the American College of Cardiology, 2015-03, Vol.65 (8), p.777-786

2015

Volltextzugriff (PDF)

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Journal of the American College of Cardiology, 2015-03, Vol.65 (8), p.791-801

2015

Volltextzugriff (PDF)

Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates

Journal of the American College of Cardiology, 2015-03, Vol.65 (8), p.805-815

2015

Volltextzugriff (PDF)

Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?

Cardiovascular research, 2020-03, Vol.116 (3), p.505-519

2020

Volltextzugriff (PDF)

Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial

The Lancet (British edition), 2019-07, Vol.394 (10194), p.230-239

2019

Volltextzugriff (PDF)

Coronary balloon angioplasty, stents, and scaffolds

The Lancet (British edition), 2017-08, Vol.390 (10096), p.781-792

2017

Volltextzugriff (PDF)

Short-Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial

Circulation (New York, N.Y.), 2012-04, Vol.125 (16), p.2015-2026

2012

Volltextzugriff (PDF)

A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study

Journal of the American College of Cardiology, 2012-12, Vol.60 (24), p.2473-2480

2012

Volltextzugriff (PDF)

Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis

Arteriosclerosis, thrombosis, and vascular biology, 2015-09, Vol.35 (9), p.1945-1953

2015

Volltextzugriff (PDF)

Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial

JACC. Cardiovascular interventions, 2013-10, Vol.6 (10), p.999-1009

2013

Volltextzugriff (PDF)

Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis

JACC. Cardiovascular interventions, 2011-10, Vol.4 (10), p.1057-1066

2011

Volltextzugriff (PDF)

Clinical end points in coronary stent trials : A case for standardized definitions

Circulation, 2007-05, Vol.115 (17), p.2344-2351

2007

Volltextzugriff (PDF)

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)

JACC. Cardiovascular interventions, 2013-09, Vol.6 (9), p.914-922

2013

Volltextzugriff (PDF)

Exosome-Loaded Pro-efferocytic Vascular Stent with Lp-PLA 2 -Triggered Release for Preventing In-Stent Restenosis

ACS nano, 2022-09, Vol.16 (9), p.14925-14941

2022

Volltextzugriff (PDF)

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial

Circulation. Cardiovascular interventions, 2015-02, Vol.8 (2), p.e001441-e001441

2015

Volltextzugriff (PDF)

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

Circulation (New York, N.Y.), 2012-01, Vol.125 (3), p.505-513

2012

Volltextzugriff (PDF)

Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: Nordic Bifurcation Study 5-Year Follow-Up Results

Journal of the American College of Cardiology, 2013-07, Vol.62 (1), p.30-34

2013

Volltextzugriff (PDF)

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials

Circulation (New York, N.Y.), 2012-06, Vol.125 (23), p.2873-2891

2012

Volltextzugriff (PDF)

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

The New England journal of medicine, 2009-01, Vol.360 (3), p.213-224

2009

Volltextzugriff (PDF)

Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis

Journal of the American College of Cardiology, 2011-02, Vol.57 (5), p.538-545

2011

Volltextzugriff (PDF)

Coronary stents: current status

Journal of the American College of Cardiology, 2010-08, Vol.56 (10 Suppl), p.S1-42

2010

Volltextzugriff (PDF)

1 – 25 von 3.239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.903)
Mit Volltextzugriff
(2.556)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.913)
Coronary Restenosis - Prevention & Control
(2.812)
Science & Technology
(2.413)
Life Sciences & Biomedicine
(2.340)
Cardiovascular System & Cardiology
(1.823)
Cardiac & Cardiovascular Systems
(1.736)
Stents
(1.664)
Male
(1.522)
Female
(1.339)
Middle Aged
(1.166)
Treatment Outcome
(1.140)
Aged
(948)
Restenosis
(866)
Biological And Medical Sciences
(854)
Medical Sciences
(845)
Drug-Eluting Stents
(773)
Coronary Angiography
(767)
Angioplasty, Balloon, Coronary
(679)
Animals
(627)
Coronary Restenosis - Etiology
(594)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents

Drug-eluting stents in coronary arteries. The risk of restenosis is drastically reduced

Drug-eluting stents can increase the risk of late stent thrombosis

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates

Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?

Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial

Coronary balloon angioplasty, stents, and scaffolds

Short-Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial

A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study

Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis

Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial

Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis

Clinical end points in coronary stent trials : A case for standardized definitions

Exosome-Loaded Pro-efferocytic Vascular Stent with Lp-PLA 2 -Triggered Release for Preventing In-Stent Restenosis

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: Nordic Bifurcation Study 5-Year Follow-Up Results

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis

Coronary stents: current status

Suchergebnisse filtern